M. Machwate et al., C-FOS PROTOONCOGENE IS INVOLVED IN THE MITOGENIC EFFECT OF TRANSFORMING GROWTH-FACTOR-BETA IN OSTEOBLASTIC CELLS, Molecular endocrinology, 9(2), 1995, pp. 187-198
We investigated the contribution of c-fos protooncogene in the mitogen
ic effect of transforming growth factor-beta (TGF beta) in serum-depri
ved, confluent rat calvaria osteoblastic cells. The TGF beta-induced g
rowth in these cells was associated with an immediate and transient c-
fos mRNA accumulation, similar to the inductive effect of fetal calf s
erum. To assess the role of c-fos in the response to TGF beta, we used
a c-fos antisense (AS) oligonucleotide displaying duplex formation wi
th rat c-fos mRNA. Studies of AS and sense (S) uptake by osteoblastic
cells demonstrated that incorporation of labeled oligomers was maximal
at 2 h, and the incorporated AS oligonucleotide remained intact for 2
4 h. Immunofluorescence analysis of c-Fos-labeled cells demonstrated t
hat AS, but not S, oligonucleotide reduced c-Fos protein expression, s
uggesting specific efficient inhibition of c-fos translation by the AS
oligomer. Proliferation assays showed that cell growth induced by fet
al calf serum was inhibited by the AS, but not by the S oligonucleotid
e, in both normal rat osteoblasts and ROS 17/2.8 osteosarcoma cells, d
emonstrating efficient and specific blockage of cell growth by the AS
oligomer. The mitogenic effect of TGF-P was abolished in cells culture
d in the presence of AS, whereas S had no effect, showing that c-fos i
s required for TGF beta-induced osteoblast cell growth. The results sh
ow that the induction of c-fos is implicated in the mitogenic effect o
f TGF beta in osteoblastic cells and provide a cellular mechanism invo
lved in the response of these cells to TGF beta.